コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 way contractility is primarily determined by airway smooth muscle.
2 responsiveness: the excessive contraction of airway smooth muscle.
3 tify the subcellular localization of CFTR in airway smooth muscle.
4 pe 17 cytokines cause hyperresponsiveness of airway smooth muscle.
5 ause of airway obstruction is contraction of airway smooth muscle.
6 airway epithelium, vascular endothelium, and airway smooth muscle.
7 per-responsiveness through direct effects on airway smooth muscle.
8 ing signaling and growth inhibition in human airway smooth muscle.
9 drenergic receptor signaling and function in airway smooth muscle.
10 tion of GPCR signaling and function in human airway smooth muscle.
11 nhanced, methacholine-induced contraction of airway smooth muscle.
12 r regulation of RLC phosphorylation in tonic airway smooth muscle.
13 ell as on bradykinin-induced contraction, in airway smooth muscle.
14 responsiveness: the excessive contraction of airway smooth muscle.
16 esults reveal stereotyped differentiation of airway smooth muscle adjacent to nascent epithelial buds
17 ilia, mast cell hyperplasia, IgE production, airway smooth muscle alterations, and airways hyperreact
18 4 (RGS4), a cytoplasmic protein expressed in airway smooth muscle and bronchial epithelium that regul
19 ted the hypothesis that CFTR is expressed in airway smooth muscle and directly affects airway smooth
20 s PIP5K1gamma is the major source of PIP2 in airway smooth muscle and its activity is regulated by hi
22 prevailing hypothesis focuses on contracting airway smooth muscle and posits a nonlinear dynamic inte
23 to the sarcoplasmic reticulum compartment of airway smooth muscle and regulates airway smooth muscle
25 icated in the control of oxidative stress in airway smooth muscle and their role in contractility.
26 transgelin-2 with specific agonists relaxes airway smooth muscles and reduces pulmonary resistance i
27 confirmed the presence of CHRNA5/3 in lung, airway smooth muscle, and bronchial epithelial cells.
28 LC phosphorylation during the contraction of airway smooth muscle, and that it regulates contraction
29 marked contraction and delayed relaxation of airway smooth muscle, and that this is mediated by the d
30 stem, alpha5-containing GABA(A) receptors in airway smooth muscles are considered as an emerging targ
32 insulin promotes beta-AR desensitization in airway smooth muscle (ASM) and compromises airway relaxa
34 olatile odorants on the contractile state of airway smooth muscle (ASM) and uncovered a complex mecha
35 h persistent airflow obstruction had greater airway smooth muscle (Asm) area with decreased periostin
37 elated mechanism along the cholinergic nerve-airway smooth muscle (ASM) axis that underlies prolonged
38 in vivo evidence of GC-resistant pathways in airway smooth muscle (ASM) bundles that can be modeled i
40 the existence of GC-insensitive pathways in airway smooth muscle (ASM) caused by a defect in GC rece
41 n-coupled bitter taste receptors (TAS2Rs) in airway smooth muscle (ASM) causes a stronger bronchodila
43 ating the bronchial submucosa and disrupting airway smooth muscle (ASM) cell-extracellular matrix (EC
46 (HS) and chondroitin sulfate (CS) by murine airway smooth muscle (ASM) cells in the presence of radi
49 n to have extraoral localizations, including airway smooth muscle (ASM) cells, in which TAS2R have be
51 in vitro model of bacterial exacerbation in airway smooth muscle (ASM) cells, we show that activatio
57 d desensitization as a means of manipulating airway smooth muscle (ASM) contractile state, we assesse
59 ll and molecular biology of inflammation and airway smooth muscle (ASM) contractility have identified
61 ary for ACh-induced actin polymerization and airway smooth muscle (ASM) contraction, but the mechanis
64 othesized that the transcriptomic profile of airway smooth muscle (ASM) distinguishes atopic asthma f
65 or crosstalk between mAChRs and beta2ARs in airway smooth muscle (ASM) helps determine the contracti
69 factor receptor staining), mucin expression, airway smooth muscle (ASM) hypertrophy and inflammatory
70 ge in early life led to a 2-fold increase in airway smooth muscle (ASM) innervation (P<0.05) and pers
71 NF), on airway contractility [ via increased airway smooth muscle (ASM) intracellular calcium [Ca(2+)
75 osition of extracellular matrix (ECM) in the airway smooth muscle (ASM) layer as observed in asthma m
76 r can be exploited to alter, the increase in airway smooth muscle (ASM) mass and cellular remodeling
80 uding asthma, are characterized by increased airway smooth muscle (ASM) mass that is due in part to g
82 (Epac), not PKA, mediates the relaxation of airway smooth muscle (ASM) observed with beta-agonist tr
85 t to beta2AR physiological function, such as airway smooth muscle (ASM) relaxation leading to broncho
87 o be expressed on extraoral cells, including airway smooth muscle (ASM) where they evoke relaxation.
89 g abnormalities in structural cells, such as airway smooth muscle (ASM), contribute to the asthmatic
90 reticular basement membrane (RBM) thickness, airway smooth muscle (ASM), mucus gland area, vascularit
91 educed IL-13-induced release of eotaxin from airway smooth muscle (ASM), similar to effects of these
102 regard, TSLP appears to also be expressed in airway smooth muscle (ASM); however, its role is unknown
103 tension generation during the contraction of airway smooth muscle (ASM); however, the role of VASP in
104 Beta-agonist-promoted desensitization of airway smooth muscle beta-2-adrenergic receptors, mediat
106 2 cysLT receptors (CysLTRs), which constrict airway smooth muscle, but elicits airflow obstruction an
108 a negative correlation desmin expression in airway smooth muscle cell (ASMC) and airway hyperrespons
109 endent, NF-kappaB-dependent allergen-induced airway smooth muscle cell (ASMC) hyperproliferation and
112 CXCL1, CXCL2, and CXCL3) production promoted airway smooth muscle cell (ASMC) migration, and conseque
115 rosine kinase inhibition directly attenuates airway smooth muscle cell contraction independent of its
118 Here, Abi1 knockdown by shRNA reduced human airway smooth muscle cell migration, which was restored
121 Here, we answer these two questions, using airway smooth muscle cells (ASMC) as a specific example.
122 relative CS insensitivity has been shown in airway smooth muscle cells (ASMC) from patients with SA.
124 corticosteroid insensitivity was present in airway smooth muscle cells (ASMCs) of patients with seve
126 o be important in regulating healthy primary airway smooth muscle cells (ASMCs), whereas changed expr
127 same receptor to preferentially colonize at airway smooth muscle cells (ASMCs)-a rich source of coll
133 ion, we developed coculture systems of human airway smooth muscle cells (HASM) with primary human mas
135 of human lung mast cells (HLMCs) with human airway smooth muscle cells (HASMCs) are partially depend
141 tion of hyaluronan "cables" in primary mouse airway smooth muscle cells (MASM) and primary human airw
143 0019), bronchial epithelial (P = 0.0002) and airway smooth muscle cells (P = 0.0352) of patients with
144 2-dependent gene expression in primary human airway smooth muscle cells and the human monocytic cell
146 o in adjacent mesenchymal tissues, including airway smooth muscle cells and their extracellular prote
147 of TRPA1 in human lung myofibroblasts, human airway smooth muscle cells but not lung mast cells.
148 hown to relax the myosin cytoskeleton of the airway smooth muscle cells by acting as a receptor for e
152 his study, we defined the mechanism in human airway smooth muscle cells from nonasthmatic and asthmat
156 ed cAMP accumulation (0-30 minutes) in human airway smooth muscle cells in the presence and absence o
157 kewise, knockdown of IQGAP1 in primary human airway smooth muscle cells increased RhoA activity.
159 fy autocrine prostaglandin E(2) signaling in airway smooth muscle cells that eventually triggered cAM
160 the most effective bronchodilators and relax airway smooth muscle cells through increased cAMP concen
161 morphology, adhesion, and migration of human airway smooth muscle cells transfected with PKAc variant
163 hi isolated from human lung tissue and human airway smooth muscle cells were treated for 2 and 1 day(
164 GC occurred in human lung slices or in human airway smooth muscle cells when given chronic NO exposur
165 The molecular mechanisms responsible for airway smooth muscle cells' (aSMCs) contraction and prol
169 (TAS2R14) is a GPCR also expressed on human airway smooth muscle cells, which signals to intracellul
177 sHA rapidly activated RhoA, ERK, and Akt in airway smooth-muscle cells, but only in the presence of
179 nsiveness, but how they interact to regulate airway smooth muscle contractility is not fully understo
184 , Drosophila) gene (PDE4D) is a regulator of airway smooth-muscle contractility, and PDE4 inhibitors
185 ium are a vital mechanism for the control of airway smooth muscle contraction and thus are a critical
186 ium are a vital mechanism for the control of airway smooth muscle contraction and thus are a critical
187 n alpha9beta1 appears to serve as a brake on airway smooth muscle contraction by recruiting SSAT, whi
188 eta1 increased in vitro airway narrowing and airway smooth muscle contraction in murine and human air
189 3-muscarinic acetylcholine receptor mediated airway smooth muscle contraction is poorly understood.
192 er, these data indicate that IL-17A promotes airway smooth muscle contraction via direct recruitment
195 ay branching morphogenesis, the frequency of airway smooth muscle contraction, and the rate of develo
206 is required for normal tension generation in airway smooth muscle during contractile stimulation and
207 itical role for localized differentiation of airway smooth muscle during epithelial bifurcation in th
208 oupling the airway to cross-bridge models of airway smooth muscle dynamics and force generation.
209 ysteresis loops are highly dependent on both airway smooth muscle dynamics, and the length-tension re
210 rnative pathway that involves activating the airway smooth muscle enzyme, soluble guanylate cyclase (
214 ARHGEF1 expression was also enhanced in airway smooth muscle from asthmatic patients and ovalbum
215 he asthmatic environment as in vitro primary airway smooth muscle from individuals with asthma compar
219 ncluding airways inflammation, alteration in airway smooth muscle function, and airway remodeling.
222 racellular matrix, which enhanced subsequent airway smooth muscle growth by 1.5-fold (P < 0.05), whic
223 of disease; however, the ability to prevent airway smooth muscle growth was lost after the progressi
224 ty by transiently increasing MMP activation, airway smooth muscle growth, and airway responsiveness.
225 h in turn increased epithelial viral burden, airway smooth muscle growth, and type 2 inflammation.
226 In asthma, mast cells are associated with airway smooth muscle growth, MMP-1 levels are associated
227 ed intracellular signaling and primary human airway smooth muscle growth, whereas only FR900359 effec
228 abundant microRNA expressed in primary human airway smooth muscle (HASM) cells, accounting for > 20%
230 sserted both EP2 and EP4 expression in human airway smooth muscle (HASM), a recent study asserted EP4
231 ce that prolonged exposure of cultured human airway smooth muscle (HuASM) cells to beta(2)-agonists d
234 membrane thickening, subepithelial fibrosis, airway smooth muscle hyperplasia and increased angiogene
235 out of Plk1 attenuated airway resistance and airway smooth muscle hyperreactivity in a murine model o
237 translational control pathway contributes to airway smooth muscle hypertrophy in vitro and in vivo.
239 thase kinase-3beta (GSK-3beta) inhibition in airway smooth muscle hypertrophy, a structural change fo
240 (damage) include bronchial wall thickening, airway smooth muscle hypertrophy, bronchiectasis and emp
243 TLR7 was expressed on airway nerves, but not airway smooth muscle, implicating airway nerves as the s
244 te whether the burden of oxidative stress in airway smooth muscle in asthma is heightened and mediate
245 We examined the oxidative stress burden of airway smooth muscle in bronchial biopsies and primary c
246 ially relevant was the mast cell increase in airway smooth muscle in CLE, which related significantly
247 ound that the oxidative stress burden in the airway smooth muscle in individuals with asthma is heigh
248 m for regulating the function of vinculin in airway smooth muscle in response to contractile stimulat
250 r demonstrate that during development, while airway smooth muscle is dispensable for epithelial branc
252 hoA translocation and Rho-kinase activity in airway smooth muscle largely via ARHGEF1, but independen
253 Furthermore, exposure to allergens enhanced airway smooth muscle layer and paxillin phosphorylation
254 enesis of allergen-induced thickening of the airway smooth muscle layer by affecting paxillin phospho
256 Here, we showed that integrin alpha9beta1 on airway smooth muscle localizes the polyamine catabolizin
258 ated gene-6) to the culture medium of murine airway smooth muscle (MASM) cells, would enhance leukocy
259 OVA-treated mice, concomitant with increased airway smooth muscle mass and peribronchial collagen dep
260 proposed mechanisms underlying the increased airway smooth muscle mass seen in airway remodeling of p
261 lymphoid cells type 2 (ILCs), and increased airway smooth muscle mass via recruitment of mesenchymal
262 hial thermoplasty, a new technique to reduce airway smooth muscle mass, improves symptoms and reduces
265 man asthma such as increased mitochondria in airway smooth muscle, platelet activation and subepithel
266 g in vivo evidence supports the concept that airway smooth muscle produces various immunomodulatory f
267 phorins 3E (Sema3E) in growth factor-induced airway smooth muscle proliferation and migration in vitr
270 del, supported by in vitro data, posits that airway smooth muscle promotes lung branching through per
271 uding cardiomyocytes, pulmonary vascular and airway smooth muscle, proximal vascular endothelium, and
272 gene ablation augments beta-agonist-mediated airway smooth muscle relaxation, while augmenting beta-a
274 tes extracellular matrix deposition in human airway smooth muscle remodeling via NF-kappaB pathway.
275 fluticasone monotherapy decreased peripheral airway smooth muscle remodelling after 12 weeks (p = 0.0
278 lpain using calpain knockout mice attenuated airway smooth muscle remodelling in mouse asthma models.
279 d cell proliferation of ASMCs and attenuated airway smooth muscle remodelling in mouse asthma models.
282 In the trachea and bronchi of the mouse, airway smooth muscle (SM) and cartilage are localized to
283 deficiency in utero correlates with abnormal airway smooth muscle (SM) function in postnatal life.
284 (AHR) and lung inflammation in germline and airway smooth muscle-specific Rgs4(-/-) mice and in mice
285 gonists used to combat hypercontractility in airway smooth muscle stimulate beta2AR-dependent cAMP pr
288 ls of airway remodeling, including increased airway smooth muscle, subepithelial fibrosis, and mucus.
290 mouse, mesenchymal cells differentiate into airway smooth muscle that wraps around epithelial branch
291 esses evoking airway hyperresponsiveness and airway smooth muscle thickening occur independent from i
292 22, enhanced contractile force generation of airway smooth muscle through an IL-17 receptor A (IL-17R
298 Reticular basement membrane thickness and airway smooth muscle were increased in patients with STR
299 of airway inflammation, mucus, fibrosis, and airway smooth muscle were no different in Ormdl3(Delta2-
300 n-dependent signaling mediates relaxation of airway smooth muscle, whereas beta-arrestin-dependent si